Pfizer’s vaccine manufacturing arm added more than 60 per cent to overall company revenue. AP
Pfizer’s vaccine manufacturing arm added more than 60 per cent to overall company revenue. AP
Pfizer share price jumps after Q3 profit beats estimates on strong vaccine sales
New York-based drug maker’s net profit climbed to $8.15bn in the three-month period to the end of September from $1.46bn a year ago
